Discontinuation report CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML
Report ID | 11847 |
Drug Identification Number | 02163675 |
Brand name | CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML |
Common or Proper name | Cefprozil |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CEFPROZIL |
Strength(s) | 125MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | ORAL |
Packaging size | 1 BTL X 75 mL and 1 BTL X 100 ML |
ATC code | J01DC |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-12-29 |
Remaining supply date | 2017-12-29 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-06-05 | English | Compare |
v2 | 2017-06-05 | French | Compare |
v3 | 2017-12-30 | English | Compare |
Showing 1 to 3 of 3